Filing Flows › Health Care › Alphatec Holdings (ATEC)
Alphatec Holdings (ATEC) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Oct 29, 2026 · Alphatec Holdings (ATEC) Q3 2026 earnings results →
Q3 2026 Revenue up 13% year over year to $221M · 2¢ of every $1 of revenue lost · operating margin 1.5%
Alphatec Holdings made $221M in Q3 2026 (+13% Y/Y). Operating margin 1.5%, net loss $5.5M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Oct 29, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $221.2M in Q3 2026, up 13% year over year and up 4% from the previous quarter.
Gross margin was 71.5%, up 1.7 points from Q3 2025. Operating profit was $3.2M, a 1.5% margin (up 9.6 points year over year). Operating expenses grew 1% against revenue growth of 13%. The quarter ended with a net loss of $5.5M, narrower than the previous quarter's $25.8M loss. Net interest and other expense of $6.7M was the main reason.
Operating cash flow was $18.9M (up 34% year over year). Non-cash charges added back $20.5M of depreciation and amortization and $14.0M of share-based compensation. Working capital and other items used $10.1M. Capital expenditures of $13.3M left free cash flow of $5.6M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Oct 29, 2026 | $221M | +13% | 1.5% | −$5.5M | $18.9M |
| Q2 2026 | 10-Q | Aug 4, 2026 | $214M | +15% | -0.9% | −$25.8M | $20.5M |
| Q1 2026 | 10-Q | May 5, 2026 | $192M | +14% | -11.8% | −$33.9M | $1.3M |
| Q4 2025 | 10-K | Feb 24, 2026 | $213M | +20% | -4.1% | −$21.7M | $20.7M |
| Q3 2025 | 10-Q | Oct 30, 2025 | $197M | +30% | -8.1% | −$28.6M | $14.0M |
| Q2 2025 | 10-Q | Jul 31, 2025 | $186M | +28% | -7.1% | −$41.1M | $15.5M |
| Q1 2025 | 10-Q | May 1, 2025 | $169M | +22% | -26.2% | −$51.9M | −$5.0M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Alphatec Holdings
ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S., and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC’s Organic Innovation Machine TM is focused on developing new approaches that integrate seamlessly with the Company’s expanding InformatiX TM platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC’s vision is to be the Standard Bearer in Spine. For more information, visit us at www.atecspine.com.
In its own words, from its 8-K, filed Aug 4, 2026.
Alphatec Holdings against its Surgical & Medical Instruments & Apparatus peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +13% against the peers' median +5%. Operating margin: 1.5% against the peers' median 13.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| ATEC Alphatec Holdings | Q3 2026 | $221M | +13% | 1.5% |
| MDLN Medline | Q3 2026 | $7.9B | +10% | 6.4% |
| MMM 3M | Q3 2026 | $6.6B | +1% | 23.7% |
| SYK Stryker | Q3 2026 | $6.5B | +8% | 15.9% |
| BSX Boston Scientific | Q3 2026 | $5.1B | +1% | 16.1% |
| BDX Becton Dickinson | Q3 FY26 | $5.0B | +5% | 13.3% |
| BAX Baxter International | Q3 2026 | $3.0B | +5% | 7.6% |
| SOLV Solventum | Q3 2026 | $1.9B | -7% | 3.5% |
| RMD ResMed | Q1 FY27 | $1.4B | +6% | 32.0% |
Source: Alphatec Holdings 10-Q on SEC EDGAR · CIK 1350653 · Surgical & Medical Instruments & Apparatus
Guidance and outlook
13F: who owns ATEC and who is buying
More on ATEC
- How Alphatec Holdings makes money: revenue by segment
- Alphatec Holdings next earnings date and what analysts expect
- Alphatec Holdings stock forecast, price target and fair value
- Who owns Alphatec Holdings stock: holders, funds and Congress trades
- Alphatec Holdings guidance and outlook
- Is Alphatec Holdings a takeover target? LBO and rumors
- Alphatec Holdings recalls, complaints and regulation
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results